ClinicalTrials.Veeva

Menu

Multimedia-based Hormonal Therapy Information Program for Patients With Prostate Cancer

N

National Taipei University of Nursing and Health Sciences

Status

Completed

Conditions

Prostatic Neoplasms

Treatments

Other: Multimedia-Based Hormone Therapy Information Program

Study type

Interventional

Funder types

Other

Identifiers

NCT04693910
201602024B0C501

Details and patient eligibility

About

This study takes place in the Divisions of Urology. Patients who have only received hormonal therapy will be enrolled. Patients will be randomly sorted into an experimental group and a control group after completing a pretest questionnaire. The experimental group will receive the the multimedia hormone therapy information program once per week for 6 consecutive weeks, while the control group will receive routine care. The follow-up data collections will be completed at 8 and 12 weeks after the pretest. For quantitative measurement, the main variables will be social support, self-efficacy, quality of life, and positive thinking.

Full description

This study takes place in the Divisions of Urology at Chang Gung Memorial Hospitals. Patients who have only received hormonal therapy will be enrolled. With reference to past research findings, self-efficacy theory, and experts' advice, a multimedia hormone therapy information program was developed. The multimedia hormone therapy information program covered 6 topics, namely the recognition of hormone therapy and multimedia information programs, mindfulness, exercise, stress relief, positive thinking, and prevention or reduction of fatigue. A pilot study will be conducted to check the feasibility of intervention study design and the effectiveness of the program will be tested. Patients will be randomly sorted into an experimental group (multimedia information group, n = 36 to 40) and a control group (routine care group, n = 36 to 40) after completing a pretest questionnaire. The experimental group will receive the multimedia information intervention once per week for 6 consecutive weeks, while the control group will receive routine care. The follow-up data collections will be completed at 8 and 12 weeks after the pretest. For quantitative measurement, the main variables will be social support, self-efficacy, quality of life, positive thinking, and satisfaction with program. Generalized Estimating Equations (GEEs) will be used to o analyze data.

Enrollment

80 patients

Sex

Male

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. patients with prostate cancer who were receiving hormonal therapy
  2. patients were at least 20 years old
  3. patients were ability to communicate in Chinese or Taiwanese
  4. the married partner agrees to study together, or the single patient has a cohabitation partner who agrees to study together.
  5. patients or family have a smart phone or tablet and can connect to the Internet.

Exclusion criteria

  1. having a history of other cancers
  2. unknown diagnosis of prostate cancer or unknown disease status
  3. patients who received chemotherapy, radiotherapy, radical prostatectomy or other treatments for prostate cancer in the past
  4. having history of mental disorder, e.g., phobia, obsessive-compulsive disorder, generalized anxiety, , major depression, mania, manic-depressive psychosis, or dementia
  5. the score of Eastern Cooperative Oncology Group performance is ≧ 2

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

Multimedia information group
Experimental group
Description:
The experimental group received a weekly multimedia hormone therapy information program for 6 weeks.
Treatment:
Other: Multimedia-Based Hormone Therapy Information Program
Routine care group
No Intervention group
Description:
The control group will receive routine care.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems